Key Takeaways:
- Solis Agrosciences has secured Series A funding from Cultivation Capital to expand commercial operations and product offerings.
- The company provides specialized agricultural research services, including plant transformation and gene editing.
- Solis serves both AgTech startups and major multinational agricultural companies, offering a capital-efficient service model.
- In 2024, Solis expanded its management team, acquired Ferris Genomics, and secured a license for the Pairwise Fulcrum™ Platform.
- The company operates from St. Louis’ 39 North AgTech Innovation District with a team of over 30 industry scientists.
Solis Agrosciences Secures Investment to Drive AgTech Innovation
Solis Agrosciences, a provider of high-quality agricultural research services, has secured Series A funding from Cultivation Capital to fuel its commercial growth and expansion. The investment will help enhance Solis’ service offerings, which support startups and large agribusinesses in bringing new innovations to market.
“Solis is led by a seasoned management team and provides a differentiated offering in the AgTech marketplace,” said Kyle Welborn, General Partner at Cultivation Capital. “We’ve been impressed by their rapid growth across a diverse customer base. Solis works side-by-side with top venture-backed startups and Big Ag clients to bring new solutions to growers.”
Founded to address a gap in specialized agricultural research, Solis offers capital-efficient access to scientific expertise and infrastructure through a service-based model. The company has quickly gained traction among both emerging AgTech firms and multinational agricultural companies.
Expanding Capabilities in AgTech Research
In 2024, Solis Agrosciences expanded its capabilities, making significant advancements in genomics and gene-editing technology. Key milestones include:
✅ Strengthening its management team with experienced industry leaders.
✅ Acquiring Ferris Genomics, enabling whole-genome sequencing capabilities.
✅ Securing a license to the Pairwise Fulcrum™ Platform, advancing gene-editing research.
✅ Increasing sales and commercial partnerships.
“We are pleased to welcome Cultivation Capital to our strong investor syndicate,” said Charlie Bolten, Co-Founder and CEO of Solis Agrosciences. “I’ve previously worked with Cultivation Capital on many great companies, and I know their team brings broad networks and deep experience to our business.”
The company’s research and innovation efforts are based in St. Louis’ 39 North AgTech Innovation District, where over 30 industry scientists work on solutions for crop science and agricultural biotechnology.
Strategic Investment and Future Growth By Solis Agrosciences
Solis Agrosciences’ Series A round was backed by a diverse group of major AgTech investors, including:
- Hermann Companies
- Jim McKelvey’s Saloniki Investments
- BioGenerator Ventures
- QRM Capital
- Cultivation Capital
